发明授权
- 专利标题： Therapeutic agent for corneal disease
- 专利标题（中）： 角膜疾病治疗剂
-
申请号： US12685860申请日： 2010-01-12
-
公开(公告)号： US08268824B2公开(公告)日： 2012-09-18
- 发明人: Takahito Kimura , Shigeto Fujishita , Hiroyoshi Kawada
- 申请人： Takahito Kimura , Shigeto Fujishita , Hiroyoshi Kawada
- 申请人地址： JP Toyama-shi
- 专利权人： Teika Pharmaceutical Co., Ltd.
- 当前专利权人： Teika Pharmaceutical Co., Ltd.
- 当前专利权人地址： JP Toyama-shi
- 代理机构： Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- 优先权： JP2005-129450 20050427
- 主分类号： A61K31/53
- IPC分类号： A61K31/53
摘要：
A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
公开/授权文献
- US20100113456A1 THERAPEUTIC AGENT FOR CORNEAL DISEASE 公开/授权日：2010-05-06
信息查询
